Suggestions
Shreefāl Mehta
Executive In Residence @ Columbia Technology Ventures | New Ventures and Commercialization Member of Research and Entrepreneurial Advisory Committee to Govt of India, Dept of Biotechnology (BIRAC)
Shreefāl Mehta is a prominent entrepreneur and investor with over 25 years of experience in the biotechnology sector. He currently serves as a member of the Research and Entrepreneurial Advisory Committee at the Department of Biotechnology, Government of India, specifically under BIRAC (Biotechnology Industry Research Assistance Council). His role involves advising on strategies to foster innovation and entrepreneurship within the biotechnology landscape in India.
In addition to his work with the Indian government, Mehta is also an Executive in Residence at Columbia Technology Ventures in New York City, where he focuses on commercializing biomedical technologies. His extensive background includes significant contributions to biotech commercialization and entrepreneurship, making him a key figure in the industry.12
Highlights
Reading this article in NYT today reminded me of why i co-founded www.repoxegen.com - people working for decades on Alzheimer's amyloid targeting drugs are very convinced that they have read the signals right but while they still keep testing their multi-billion investments, we as a society have to continue robustly investing in and evaluating new approaches, new targets, as there are so many paths to the pathologies we see in Alzheimer's and other neuro-degenerative diseases... We need more shots on goal!!
Our startup (Repoxegen Therapeutics) is getting ready to engage in this development landscape as we have just completed licensing in our oral small molecule targeting an enzyme that seems to be a master switch from chronic neuro-inflammation to resolving homeostasis and neuroprotection. Wish us luck and godspeed!! If you feel like giving us a tangible boost, drop a check into our pre-seed founders and friends round now (we will soon step up the round terms to recognize this major milestone.. )
https://lnkd.in/d8c7tV-J?
A visit to the Whitney today revealed a reflection in the arts of the intense dialogues around AI technology going on in society today. Not only in the 2024 Biennial but also in the Whitney collection - in particular I was amazed to see the revival of the AARON project (by Harold Cohen) which used AI and a plotter to make new art by machine as maker in the 1970s!! They had revived this Al software and a plotter was making new pieces of art as we walked around talking loudly with no regard to disturbing AARON’s artistic “flow”. :-)
(You might be able to read the text in the photos by magnifying )
Very cool to see the various artists response to societal issues and their unique artistic expressions in the biennial and the Whitney collection.
